also on other fortune lists

company facts

f500 stats

Fortune 500

Courtesy of Nick Collura/Cardinal Health


Cardinal Health


The $136.8 billion revenue drug wholesaler and medical supplier managed 5.3% sales growth in 2018 despite an increasingly challenging environment largely due to greater sales of high-price drugs used in oncology, among other medical specialties. The bulk of Cardinal’s revenue comes from the medications it distributes to pharmacies and is impacted by fluctuations in drug prices. The declining price of generics has weighed on the company’s bottom line in recent years and the heightened scrutiny of drug pricing has created uncertainty for Cardinal and its two bigger rivals, McKesson and AmerisourceBergen. The industry is also under continued pressure—and faces a growing number of lawsuits—over its alleged role in the nation’s opioid epidemic.

Looking for leads, investment insights, or competitive intelligence?


Michael C. Kaufmann

CEO Title

Chairman & Chief Executive Officer


Health Care


Wholesalers: Health Care

HQ Location

Dublin, Ohio

Years on Fortune 500 List




Figures are for fiscal year ended June 30, 2018.
Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$136,8095.3%
Profits ($M)$256.0-80.1%
Assets ($M)$39,951
Total Stockholder Equity ($M)$6,059
Profit Ratios
Profit as % of Revenues0.2%
Profits as % of Assets0.6%
Profits as % of Stockholder Equity4.2%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)0.81
EPS % Change (from 2017)-79.9%
EPS % Change (5 year annual rate)-3.5%
EPS % Change (10 year annual rate)-13.8%
Total Return
Total Return to Investors (2018)-24.8%
Total Return to Investors (5 year, annualized)-5.6%
Total Return to Investors (10 year, annualized)8.4%
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Cardinal Health

The Justice Department Is Getting In on the War on Opioids

Attorney General Jeff Sessions announced a "statement of intent" to prop up suits against opioid makers and distributors.

Read More →
Amazon, Berkshire Hathaway and J.P. Morgan Are Forming a Non-Profit Health Care Venture

Sparking a selloff in the shares of a host of health care-related companies.

Read More →
Bluegonegone: China's bike-sharing bubble goes bust

The special Sino Saturday edition of CEO Daily.

Read More →